| abstract |
A method is provided for determining whether a treatment protocol for a human patient who is suffering from heart failure, ischemic heart disease, cardiac arrhythmias, or hypertension includes administration of a beta blocker, the method including obtaining a biological sample from the patient, determining a β 1 -adrenergic receptor (β 1 AR) sequence of a β 1 AR gene from the biological sample, identifying locations of any polymorphisms in the β 1 AR sequence, assigning a haplotype to the β 1 AR sequence based on the locations identified, and determining whether the treatment protocol includes administration of a beta blocker to the patient based on the haplotype assigned. |